Please use this identifier to cite or link to this item: http://hdl.handle.net/10419/39888
Authors: 
Schustereder, Ingmar
Jütting, Johannes P.
Year of Publication: 
2008
Series/Report no.: 
Proceedings of the German Development Economics Conference, Zürich 2008 19
Abstract: 
This paper analyzes the impact of trade related intellectual property rights (TRIPS) on drug prices in seven middle income countries. Applying both an econometric as well as an explorative analysis we find three key messages: First, the introduction of TRIPS in the selected countries tends to have no major impact on the development of drug prices. Country specic factors like excessive procurement and marketing costs seem to be more important determinants for the observed high price levels. Second, the application of TRIPS safeguards which allow countries to override TRIPS requirements appears to be an important lever to contain drug prices by encouraging competition. There seems, however, scope for improvement in the efficient use of these safeguards. Third, with respect to policy implications, middle income countries should in particular address inefficiencies in local marketing and procurement costs whereas OECD countries need to improve the coherence between trade and aid policies.
Document Type: 
Conference Paper

Files in This Item:
File
Size





Items in EconStor are protected by copyright, with all rights reserved, unless otherwise indicated.